Results 21 to 30 of about 20,476 (195)
The proliferation markers in patients with different forms of hyperplastic endometrial processes
Introduction: Endometrial hyperplastic processes (EHP) are characterized by recurrent course, high risk of malignancy, difficulties in diagnosing and predicting the course, which determines their great medical and social significance Objective: To ...
Yuri Krut +4 more
doaj +1 more source
Prevalence of Co-existing Endometrial Carcinoma in Patients with Preoperative Diagnosis of Endometrial Hyperplasia [PDF]
Introduction: Endometrial hyperplasia has been associated with the presence of concomitant endometrial carcinoma. In this study, patients who were diagnosed with endometrial hyperplasia and had hysterectomy, determination of the incidence of ...
Pinar Kadirogullari +3 more
doaj +1 more source
Prevalensi Mioma Uteri dengan Koeksistensi Hiperplasia Endometrium
Objective: This study was conducted to determine the prevalence of uterine fibroids with the coexistence of endometrial hyperplasia at RSUD Margono Soekarjo Purwokerto in the period of 2017−2019. Methods: This study used an observational cross-sectional
Nadya Hasna Rasyida Da +2 more
doaj +1 more source
Aim: To evaluate efficiency of sono-elastography in differentiation of endometrial hyperplasia and endometrial carcinoma. Patients and methods: Between January 2014 and January 2015, 45 perimenopausal female patients with endometrial thickness more than ...
Mahmoud Abdel Latif +3 more
doaj +1 more source
A Potential Invasion-Promoting Role for Ezrin in Endometrial Carcinoma [PDF]
Background:Ezrin is a cell membrane-cytoskeleton linker that is essential to maintain the normal cell shape and the integrity of cell-cell adhesion. Overexpression of ezrin is correlated with poor prognosis in several malignancies.
Ahmed R. H. Ahmed +3 more
doaj +1 more source
Concurrent Endometrial Carcinoma in Patients with a Curettage Diagnosis of Endometrial Hyperplasia
Endometrial hyperplasia is considered a precursor of endometrial carcinoma, but concurrent endometrial carcinoma in patients with endometrial hyperplasia is seen frequently.
Yu-Li Chen +5 more
doaj +1 more source
New classification system of endometrial hyperplasia WHO 2014 and its clinical implications
Endometrial hyperplasia (EH) is a pathological condition characterised by hyperplastic changes in endometrial glandular and stromal structures lining the uterine cavity. Endometrial hyperplasia, particularly with atypia, is a significant clinical concern
Katarzyna Sobczuk, Anna Sobczuk
doaj +1 more source
Background: In women with endometrial hyperplasia, there is a risk for co-existent endometrial cancer when patients are subjected to immediate surgical treatment.
Gokhan Boyraz +4 more
doaj +1 more source
Diagnostic Value of Moesin and MMP9 Immunohistochemical Expression in Differentiating Endometrial Hyperplasia and Endometrial Carcinoma [PDF]
Background: Endometrial carcinoma is a major health burden, and its development is often preceded by well-defined precursor lesions. Detection of such lesions is particularly significant for early diagnosis and appropriate treatment of endometrial ...
Manar Azzam +3 more
doaj +1 more source
Endometrial hyperplasia is caused by an excess of estrogen unopposed by progesterone. Oral progestogens are traditionally used for endometrial hyperplasia without atypia.
Ye Shen +6 more
doaj +1 more source

